Results 11 to 20 of about 542,716 (249)

New Corynebacterium Species with the Potential to Produce Diphtheria Toxin [PDF]

open access: yesPathogens, 2022
Only three Corynebacterium species are known to produce a lethal exotoxin called diphtheria toxin. These are C. diphtheriae, C. ulcerans and C. pseudotuberculosis.
Marta Prygiel   +5 more
doaj   +4 more sources

Challenges of Diphtheria Toxin Detection [PDF]

open access: yesToxins
Diphtheria toxin (DT) is the main virulence factor of Corynebacterium diphtheriae, C. ulcerans and C. pseudotuberculosis. Moreover, new Corynebacterium species with the potential to produce diphtheria toxin have also been described.
Marta Prygiel   +6 more
doaj   +5 more sources

THE PRODUCTION OF DIPHTHERIA TOXIN [PDF]

open access: yesJournal of Experimental Medicine, 1896
Toxin of sufficient strength to kill a 400-gramme guinea-pig in three days and a half in a dose of 0·cubic centimetre developed in suitable bouillon, contained in ordinary Erlenmeyer flasks, within a period of twenty-four hours. In such boullon the toxin reached its greatest strength in from four to seven days (0·005 cubic centimetre killing a 500 ...
W H, Park, A W, Williams
exaly   +4 more sources

The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells [PDF]

open access: yesScientific Reports, 2017
Diphtheria toxin kills human cells because it delivers its enzyme domain DTA into their cytosol where it inhibits protein synthesis. After receptor-mediated uptake of the toxin, DTA translocates from acidic endosomes into the cytosol, which might be ...
Manuel Schuster   +16 more
doaj   +3 more sources

Diphtheria toxin activates ribotoxic stress and NLRP1 inflammasome-driven pyroptosis. [PDF]

open access: yesJ Exp Med, 2023
This work demonstrates that diphtheria toxin is a potent trigger for the ZAKα-dependent ribotoxic stress response and the NLRP1 inflammasome in human skin cells. ZAKα inhibition is effective at limiting the skin damage caused by diphtheria toxin in vitro.
Robinson KS   +13 more
europepmc   +2 more sources

BIOLOGICAL PROPERTIES AND MEDICAL APPLICATION OF DIPHTHERIA TOXIN DERIVATIVES [PDF]

open access: yesBiotechnologia Acta, 2018
The aim of the review was to analyze the literature data related to the application of a variety of diphtheria toxin derivatives. Although studies of the diphtheria toxin interaction with sensitive and resistant mammalian cells have been held for a ...
Manoilov K.Y.
doaj   +2 more sources

A brain-sparing diphtheria toxin for chemical genetic ablation of peripheral cell lineages

open access: yesNature Communications, 2017
Diphtheria toxin selectively kills cells engineered to express the diphtheria toxin receptor (DTR). Here the authors report a PEGylated version of diphtheria toxin that does not enter the brain, allowing for ablation of only peripheral cells when using ...
Mafalda M. A. Pereira   +10 more
doaj   +2 more sources

Human antibodies neutralizing diphtheria toxin in vitro and in vivo. [PDF]

open access: yesSci Rep, 2020
Diphtheria is an infectious disease caused by Corynebacterium diphtheriae. The bacterium primarily infects the throat and upper airways and the produced diphtheria toxin (DT), which binds to the elongation factor 2 and blocks protein synthesis, can ...
Wenzel EV   +9 more
europepmc   +2 more sources

Identification of formaldehyde-induced modifications in diphtheria toxin. [PDF]

open access: yesJournal of Pharmacy and Science, 2020
Diphtheria toxoid is produced by detoxification of diphtheria toxin with formaldehyde. This study was performed to elucidate the chemical nature and location of formaldehyde-induced modifications in diphtheria toxoid.
Bernard Metz   +9 more
semanticscholar   +4 more sources

Targeted Diphtheria Toxin-Based Therapy: A Review Article

open access: yesFrontiers in Microbiology, 2019
Cancer remains one of the leading causes of death worldwide. Conventional therapeutic strategies usually offer limited specificity, resulting in severe side effects and toxicity to normal tissues.
Fatemeh Shafiee   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy